Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
Cancer Research and Treatment. 2016;48(4):1399-1407 
Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reserve transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA
Journal of Pediatric Surgery. 1996;31(1):215
Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA
Cancer. 1995;75(11):2757-2761
Quantitative Analysis of Tyrosine Hydroxylase mRNA for Sensitive Detection of Neuroblastoma Cells in Blood and Bone Marrow
Clinical Chemistry. 2003;49(1):104-112
Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA
Cancer. 1996;77(6):1214-1219
651 Blood and bone marrow transcripts of tyrosine hydroxylase, dopa decarboxylase, and GD2 synthase in neuroblastoma
European Journal of Cancer Supplements. 2003;1(5):S195
Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA
European Journal of Cancer. 1995;31(4):553-556
Measurement of tyrosine hydroxylase transcripts in bone marrow using biopsied tissue instead of aspirates for neuroblastoma
Pediatric Blood & Cancer. 2010;55(2):273-278
Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction
European Journal of Cancer and Clinical Oncology. 1991;27(6):762-765
The clinical significance of hMAM mRNA expression in peripheral blood of patients with breast cancer
The Chinese-German Journal of Clinical Oncology. 2008;7(12):709-712